Anti-suicidal effectiveness of clozapine, lithium, and valproate in patients with schizophrenia and bipolar disorder: A real-world nationwide study
- 28 March 2025
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 185, 105-111
Abstract
No abstract availableKeywords
Funding Information
- Eulji University (EJBS-24-05)
This publication has 66 references indexed in Scilit:
- Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analysesEuropean Neuropsychopharmacology, 2022
- Clozapine for Treatment-Refractory Aggressive BehaviorPsychiatric Quarterly, 2020
- 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)World Psychiatry, 2020
- Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychoticsJournal of Affective Disorders, 2013
- Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2007
- The Lifetime Risk of Suicide in SchizophreniaArchives of General Psychiatry, 2005
- Suicide Risk in Bipolar Disorder During Treatment With Lithium and DivalproexJAMA, 2003
- Clozapine Treatment for Suicidality in SchizophreniaInternational Suicide Prevention Trial (InterSePT)Archives of General Psychiatry, 2003
- The epidemiology of bipolar affective disorderSocial Psychiatry and Psychiatric Epidemiology, 1995
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988